» Articles » PMID: 22881429

The Effect of a Beare-Stevenson Syndrome Fgfr2 Y394C Mutation on Early Craniofacial Bone Volume and Relative Bone Mineral Density in Mice

Overview
Journal J Anat
Date 2012 Aug 14
PMID 22881429
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Quantifying the craniofacial skeletal phenotype during development highlights potential effects of known mutations on bone maturation and is an informative first step for the analysis of animal models. We introduce a novel technique to easily and efficiently quantify individual cranial bone volume and relative bone mineral density across the murine skull from high resolution computed tomography images. The approach can be combined with existing quantitative morphometric methods to provide details of bone growth and bone quality, which can be used to make inferences about regulatory effects local to individual bones and identify locations and developmental times for which additional analyses are warranted. Analysis of the Fgfr2(+/Y394C) mouse model of Beare-Stevenson cutis gyrata syndrome, an FGFR-related craniosynostosis syndrome, is used to demonstrate the method. Mutants and unaffected littermates display similar bone volume and relative bone density at birth, followed by significant differences at postnatal day eight. The change in rates of bone volume growth occurs similarly for all bones of the skull, regardless of origin, location or association with craniosynostosis. These results suggest an association between low bone density, low bone volume, and Fgfr craniosynostosis mutations. Our novel technique provides an initial quantitative evaluation of local shifts in bone maturation across the skull of animal models.

Citing Articles

Overexpression of fibroblast growth factor receptor 2 in bone marrow mesenchymal stem cells enhances osteogenesis and promotes critical cranial bone defect regeneration.

Zhou Y, Zhu P, Shen S, Wang Y, Li B, Guo B Front Cell Dev Biol. 2023; 11:1208239.

PMID: 37266455 PMC: 10229770. DOI: 10.3389/fcell.2023.1208239.


Embryonic and early postnatal cranial bone volume and tissue mineral density values for C57BL/6J laboratory mice.

Lesciotto K, Tomlinson L, Leonard S, Richtsmeier J Dev Dyn. 2022; 251(7):1196-1208.

PMID: 35092111 PMC: 9250594. DOI: 10.1002/dvdy.458.


Developmental and Evolutionary Significance of the Zygomatic Bone.

Heuze Y, Kawasaki K, Schwarz T, Schoenebeck J, Richtsmeier J Anat Rec (Hoboken). 2016; 299(12):1616-1630.

PMID: 27870340 PMC: 5111587. DOI: 10.1002/ar.23449.


Fibroblast growth factor (FGF) signaling in development and skeletal diseases.

Teven C, Farina E, Rivas J, Reid R Genes Dis. 2015; 1(2):199-213.

PMID: 25679016 PMC: 4323088. DOI: 10.1016/j.gendis.2014.09.005.


Surface landmark quantification of embryonic mouse craniofacial morphogenesis.

Percival C, Green R, Marcucio R, Hallgrimsson B BMC Dev Biol. 2014; 14:31.

PMID: 25059626 PMC: 4222779. DOI: 10.1186/1471-213X-14-31.


References
1.
Wang Y, Xiao R, Yang F, Karim B, Iacovelli A, Cai J . Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development. 2005; 132(15):3537-48. DOI: 10.1242/dev.01914. View

2.
Beamer W, Shultz K, Donahue L, Churchill G, Sen S, Wergedal J . Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res. 2001; 16(7):1195-206. DOI: 10.1359/jbmr.2001.16.7.1195. View

3.
Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, SIZONENKO P . Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab. 1992; 75(4):1060-5. DOI: 10.1210/jcem.75.4.1400871. View

4.
Krimmel M, Niemann G, Will B, Reinert S . Surgical correction of craniosynostosis in malignant osteopetrosis. J Craniofac Surg. 2004; 15(2):218-20. DOI: 10.1097/00001665-200403000-00007. View

5.
Ornitz D, Marie P . FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002; 16(12):1446-65. DOI: 10.1101/gad.990702. View